Omkar Pharmachem Limited (BOM:532167)
India flag India · Delayed Price · Currency is INR
29.74
+1.41 (4.98%)
At close: Dec 15, 2025

Omkar Pharmachem Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
5.45.45.45.45.42.7
Revenue Growth (YoY)
----100.00%500.00%
Cost of Revenue
1.881.611.611.391.751.51
Gross Profit
3.523.793.84.013.651.19
Selling, General & Admin
0.070.070.070.070.070.06
Other Operating Expenses
0.920.830.90.840.90.91
Operating Expenses
1.030.941.010.930.980.99
Operating Income
2.492.852.783.082.670.21
Interest Expense
-0.19-0.17-0.29-0.47-0.56-0.57
Interest & Investment Income
0.020.020.040.03--
Other Non Operating Income (Expenses)
0.04-----0
EBT Excluding Unusual Items
2.362.72.532.652.11-0.36
Pretax Income
2.362.72.532.652.11-0.36
Income Tax Expense
0.960.690.640.670.27-2.57
Net Income
1.412.011.891.981.832.21
Net Income to Common
1.412.011.891.981.832.21
Net Income Growth
-24.93%6.24%-4.40%8.03%-17.30%-
Shares Outstanding (Basic)
101010101010
Shares Outstanding (Diluted)
101010101010
Shares Change (YoY)
0.02%-----
EPS (Basic)
0.140.200.190.200.180.22
EPS (Diluted)
0.140.200.190.200.180.22
EPS Growth
-24.95%6.24%-4.40%8.97%-18.02%-
Free Cash Flow
2.052.42.862.761.960.22
Free Cash Flow Per Share
0.200.240.280.270.190.02
Gross Margin
65.26%70.24%70.28%74.28%67.57%44.19%
Operating Margin
46.11%52.76%51.56%57.07%49.41%7.70%
Profit Margin
26.09%37.20%35.02%36.63%33.91%82.00%
Free Cash Flow Margin
37.87%44.35%53.02%51.09%36.30%8.30%
EBITDA
2.532.92.833.112.690.22
EBITDA Margin
46.89%53.63%52.43%57.57%49.76%8.07%
D&A For EBITDA
0.040.050.050.030.020.01
EBIT
2.492.852.783.082.670.21
EBIT Margin
46.11%52.76%51.56%57.07%49.41%7.70%
Effective Tax Rate
40.40%25.59%25.20%25.22%13.02%-
Revenue as Reported
5.475.425.445.435.42.7
Advertising Expenses
-0.030.030.030.030.03
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.